T
Toshio Fukusato
Researcher at Teikyo University
Publications - 84
Citations - 2952
Toshio Fukusato is an academic researcher from Teikyo University. The author has contributed to research in topics: Hepatocellular carcinoma & Nonalcoholic fatty liver disease. The author has an hindex of 23, co-authored 82 publications receiving 2455 citations. Previous affiliations of Toshio Fukusato include Kobe University.
Papers
More filters
Journal ArticleDOI
Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy
Tomonori Kanda,Toshio Fukusato,Megumi Matsuda,Keiko Toyoda,Hiroshi Oba,Jun'ichi Kotoku,Takahiro Haruyama,Kazuhiro Kitajima,Shigeru Furui +8 more
TL;DR: Even in subjects without severe renal dysfunction, GBCA administration causes gadolinium accumulation in the brain, especially in the DN and GP.
Journal ArticleDOI
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
TL;DR: The histopathological features of NAFLD/NASH are reviewed and interobserver agreement for evaluating the extent of steatosis and fibrosis is high, agreement is low for intralobular and portal inflammation.
Journal ArticleDOI
Rats Fed Fructose-Enriched Diets Have Characteristics of Nonalcoholic Hepatic Steatosis
Takahiro Kawasaki,Kanji Igarashi,Tatsuki Koeda,Keiichiro Sugimoto,Kazuya Nakagawa,Shuichi Hayashi,Ryoichi Yamaji,Hiroshi Inui,Toshio Fukusato,Toshikazu Yamanouchi +9 more
TL;DR: In this article, 5-week-old Wistar specific pathogen-free rats were fed experimental diets for 5 wk, and the degree of steatohepatitis was evaluated.
Journal ArticleDOI
Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement.
Yasuni Nakanuma,Yoh Zen,Kenichi Harada,Motoko Sasaki,Akitaka Nonomura,Takeshi Uehara,Kenji Sano,Fukuo Kondo,Toshio Fukusato,Koichi Tsuneyama,Masahiro Ito,Kenichi Wakasa,Minoru Nomoto,Hiroshi Minato,Hironori Haga,Masayoshi Kage,Hirohisa Yano,Joji Haratake,Shinichi Aishima,Tomoyuki Masuda,Hajime Aoyama,Aya Miyakawa-Hayashino,Toshiharu Matsumoto,Hayato Sanefuji,Hidenori Ojima,Tse Ching Chen,Eunsil Yu,Jihun Kim,Young Nyun Park,Wilson M. S. Tsui +29 more
TL;DR: This new staging and grading system for PBC seems to be more convenient and practical than those used at present, but more instruction and guidance are recommended for the grading of necroinflammatory activity in practice.
Journal ArticleDOI
Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
TL;DR: There is a lack of consensus regarding the most effective and appropriate pharmacotherapy for NAFLD/NASH, and animal experiments suggest that herbal medicines and natural products may be promising therapeutic agents, but their efficacy and safety are yet to be investigated in human studies.